Consistently, our data showed an up-regulation of NPY and AgRP in TDP-43A315T mice at disease end-stage, as previously reported by others in ALS patients and several animal models [56,57], and an overall decrease in POMC expression. This evidence concerns the gene POMC and amyotrophic lateral sclerosis.